References
- MacLennan AH, Taylor AW, Wilson DH. Changes in the use of hormone replacement therapy in South Australia. Med J Aust 1995; 162:420–2
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002;288:321–33
- Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopause estrogen and estrogen—progestin replacement therapy and breast cancer link. J Am Med Assoc 2000;283:485–91
- Ross RR, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk. J Natl Cancer Inst 2000;92:328–32
- Persson I, Yuen J, Bergvist L, Adami HO, Hoover R, Schairer C. Combined oestrogen—progestogen replacement therapy and breast cancer risk. Lancet 1992;350:1047–59
- Lee JR. Osteoporosis reversal: the role of pro-gesterone. Int Clin Nutr Rev 1990;10:384–9
- Lee JR. Use of Pro-Gest cream in postmenopausal women (Letter). Lancet 1998;352:905
- Whitehead MI, Townsend PT, Gill DK, Collins WD, Campbell S. Absorption and metabolism of oral progesterone. Br Med J 1980;1:825–7
- Ross D, Cooper AJ, Pryse-Davies J, Bergeron C, Collins WP, Whitehead MI. Randomised double-blind, dose ranging study of the endo-metrial effects of a vaginal progesterone gel in estrogen treated postmenopausal women. Am J Obstet Gynecol 1997;177:937–41
- Cooper A, Spencer C, Whitehad MI, Ross D, Barnard GJR, Collins WP. Systemic absorption of micronised progesterone from Progese cream in postmenopausal women. Lancet 1998; 351:1255–6
- Leonetti HB, Longo S, Anasti JM. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999;94:225–8
- Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000;3: 155–60
- Sherwin BM, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in surgical menopause. Psycho-som Med 1997;47:339–51
- Davis SR. Androgen treatment in women. Med J Aust 1999;170:545–9
- Bruder JM, Sobek, Oette M. Dehydro-epiandrosterone stimulates the estrogen response element. J Steroid Biochem Mol Biol 1997; 62:461–6
- Katz S, Morales AJ. Dehydroepiandrosterone (DHEA) and DHEA-sulphate (DS) as therapeutic options in menopause. Sem Reprod Endocrinol 1998;16:161–70
- Labrie F. DHEA as a physiological replacement therapy at menopause. J Endocrinol Invest 1998;21:399–401
- Shealy CN. A review of dehydroepiandrosterone (DHEA). Integ Physiol Behav Sci 1995;30: 308–13
- Raven PW, Hinson JP. DHEA and the meno-pause: a new approach to HRT? J Br Menopause Soc 2001;7:175–80
- Studd J, Pornel B, Marton I, et al. Efficacy and acceptability of intranasal 170-oestradiol for menopausal symptoms: randomised dose response study. Lancet 1999;353:1574–8
- Gompel A, Bergeron C, Jondet M, et al. Endo-metrial safety and tolerability of Aerodiol. Maturitas 2000;34:209–15
- Symposium Report. Aerodiol: pulsed estrogen therapy. Maturitas 2001;38(Suppl 1):S1–58
- Dollbaum CM, Duwe GF. Absorption of pro-gesterone after topical applications; serum and saliva levels. Presented at the 7th Annual Meeting of the American Menopause Society, September 1997, Chicago
- De Lignieres B, Silberstein S. Pharmacodynamics of oestrogen and progestogens. Cephalalgia 2000;20:200–7
- Ferenczy A, Bertrand G, Gelfand M. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J 0 bstet Gynecol 1997;133: 859–67
- Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L. 24-Hour secretory pattern of dehydroisoandrosterone and dehydroisoandro-sterone sulphate. J Clin Endocrinol Metab 1975;40: 850–5
- Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J Clin Pharmacol 1999;39:327–48
- Slater CC, Souter I, Zhang C, Guan C, Stanczyk FZ, Mishell DR Jr. Pharmacokinetics of testos-terone after percutaneous gel or buccal adminis-tration. Fertil Steril 2001;76:32–7
- Koefoed P, Braham J. The permeability of the human red cell membrane to steroid sex hor-mones. Biochim Biophys Acta 1994:1195:55–62
- Lewis JG, McGill H, Patton VM, Elder PA. Caution on the use of saliva measurement to monitor absorption of progesterone from trans-dermal creams in postmenopausal women. Maturitas 2001;41:1–6